Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using…
We aimed to develop nafamostat mesylate immediate-release tablets for the treatment of COVID-19 through drug repositioning studies of nafamostat mesylate injection. Nafamostat mesylate is a serine protease inhibitor known to inhibit the…